OKYO
OKYO Pharma Limited
NASDAQ: OKYO · HEALTHCARE · BIOTECHNOLOGY
$1.49
+0.00% today
Updated 2026-10-28
Market cap
$77.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-9.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$8.33
+459.06%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Altman Z -9.91 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-4.41M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net income | $-13.27M | $-16.83M | $-4.71M | $-8.95M | $-6.36M |
| EPS | — | — | — | — | $-0.23 |
| Free cash flow | $-7.70M | $-9.49M | $-1.81M | $-5.94M | $-4.41M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
OKYO Pharma Limited trades at $1.49. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -9.91, it sits in the distress.
Frequently asked questions
What is OKYO Pharma Limited's stock price?
OKYO Pharma Limited (OKYO) trades at $1.49.
Is OKYO Pharma Limited overvalued?
OKYO Pharma Limited carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of OKYO Pharma Limited (OKYO)?
The 12-month analyst consensus target is $8.33, about 459.1% above the current $1.49. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
OKYO Pharma Limited's Altman Z-Score is -9.91, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-2,969.00%
Beta-0.06
50D MA$1.45
200D MA$1.65
Shares out0.05B
Float0.03B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—